Interim report Q3 2019 is now available

Jon Sigurdsson, President & CEO, comments:
Sales growth in the third quarter of the year was strong with a good contribution from both prosthetics and bracing & supports while bearing in mind a strong comparable quarter last year. With strong sales growth in the first nine months of the year, we are narrowing our full year guidance for organic growth to ~6% compared to the previous guidance of 5-6%.

Please visit our Investor Relations section for further information.

About Össur

Pioneers of advanced technology, our mission is to improve people’s mobility. As a global leader in non-invasive orthopaedics, we have nurtured an innovative mind-set, continuously pushing the boundaries to create the best products and services in the fields of Prosthetic, Osteoarthritis and Injury Solutions.

True advocates of "Life Without Limitations", we work with individuals, clinicians and diverse communities around the world to support a better quality of life for millions of people.

More about Össur

Investor Relations

We serve our investors, by communicating in an informative and honest way. We are ambitious about the way we interact. It is our policy to provide investors, analysts and other stakeholders with comprehensive and accurate information to improve the understanding of the current and expected development of Össur.

Visit our Investor Information page